Vanguard Health Care Fund Investor Shares (VGHCX)

Fund Assets	38.16B
Expense Ratio	0.33%
Min. Investment	$3,000
Turnover	47.00%
Dividend (ttm)	2.24
Dividend Yield	1.03%
Dividend Growth	30.88%
Payout Frequency	Semi-Annual
Ex-Dividend Date	Mar 30, 2026

Previous Close	219.22
YTD Return	11.60%
1-Year Return	32.99%
5-Year Return	46.46%
52-Week Low	176.37
52-Week High	219.84
Beta (5Y)	0.54
Holdings	103
Inception Date	May 23, 1984

About VGHCX

For over a quarter-century, this actively managed fund has provided investors with an economical way to access a diverse range of companies operating within the global healthcare industry. Its holdings span various segments, including pharmaceutical developers, medical equipment manufacturers, and groundbreaking research institutions. Compared to other healthcare-focused funds, it generally boasts broader international exposure and tends to have a more stable portfolio with less frequent trading. However, a key consideration for investors is its specialized concentration, as all investments are exclusively confined to the healthcare sector. Given that yearly performance can fluctuate considerably, this fund is best suited as a supplementary component within a broader, well-rounded investment portfolio, especially for those with a long-term outlook.

• Fund Family: Vanguard
• Category: Health
• Performance Rating: Average
• Risk Rating: Low
• Stock Exchange: NASDAQ
• Ticker Symbol: VGHCX
• Share Class: Investor Shares
• Index: MSCI ACWI/Health Care NR Index

Performance

VGHCX had a total return of 32.99% in the past year, including dividends. Since the fund's inception, the average annual return has been 14.64%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
VGHAX	Admiral Shares	0.27%

Top 10 Holdings

41.47% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	8.83%
Merck & Co., Inc.	MRK	6.05%
AstraZeneca PLC	AZN	4.85%
Johnson & Johnson	JNJ	4.50%
UnitedHealth Group Incorporated	UNH	4.41%
GSK plc	GSK	2.97%
CVS Health Corporation	CVS	2.59%
Edwards Lifesciences Corporation	EW	2.49%
Vertex Pharmaceuticals Incorporated	VRTX	2.41%
Intuitive Surgical, Inc.	ISRG	2.37%

Dividend History

Ex-Dividend	Amount	Pay Date
Mar 30, 2026	$7.65777	Mar 31, 2026
Dec 19, 2025	$5.3174	Dec 22, 2025
Mar 28, 2025	$3.48195	Mar 31, 2025
Dec 20, 2024	$17.64181	Dec 23, 2024
Mar 27, 2024	$6.15768	Mar 28, 2024
Dec 27, 2023	$8.25288	Dec 28, 2023

Data Sources: Tiingo, Financial Modeling Prep, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Aug 27, 2026

Data Sources Report a data error